Heading: |
Breast Cancer: Medical Treatments |
Question ID: |
1820974 |
UIN: |
65926 |
House: |
Commons |
Date tabled: |
2025-07-08 |
Asking Member ID: |
5047 |
Asking Member display name: |
James Naish
|
Asking Member handle: |
|
Asking Member Twitter reference: |
James Naish
|
Member interest: |
false |
Question text: |
To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that people with incurable secondary breast cancer have access to world-leading treatments. |
Is named day: |
false |
Date of holding answer: |
|
Date answered: |
2025-07-11 |
Date answer corrected: |
|
Is holding answer: |
false |
Is correcting answer: |
false |
Answering Member ID: |
4981 |
Answering Member display name: |
Ashley Dalton
|
Answering Member handle: |
AshleyDalton_MP
|
Answering Member Twitter reference: |
@AshleyDalton_MP
|
Correcting Member ID: |
|
Correcting Member display name: |
|
Correcting Member handle: |
|
Correcting Member Twitter reference: |
|
Answer text: |
NHS England announced in April 2025 that eligible women with secondary breast cancer could soon have access to a new targeted treatment, capivasertib, used alongside fulvestrant, on the National Health Service.In May, NHS England announced the world’s fir... |
Original answer text: |
|
Comparable answer text: |
|
Answering body ID: |
17 |
Answering body name: |
Department of Health and Social Care |
Tweeted: |
true |